JP Morgan Downgrades Insulet to Neutral, Lowers Price Target to $152

Benzinga Newsdesk www.benzinga.com Negative 90.7%

Neg 90.7% Neu 0% Pos 0%

JP Morgan analyst Robbie Marcus downgrades Insulet (NASDAQ:PODD) from Overweight to Neutral and lowers the price target from $275 to $152.